ANS Biotech is an independent preclinical Contract Research Organization (CRO) fully dedicated to the pharmacology of pain. The company offers its clients a unique combination of expertise in the fundamentals of pain pharmacology and a proven record of R&D program management for new and innovative analgesics.
Our mission is to collaboratively support the drug discovery and development efforts of human and animal health
companies by offering:
> Unique early screening services to profile your drug candidates,
> Tailored solutions for the management of your research projects,
> A growing list of clinically relevant and predictive disease and efficacy in vivo models of pain,
> Comprehensive consulting services based on an extensive industrial experience.
As a close Pharma and Biotech partner, ANS Biotech commits itself to providing cost-effective preclinical pharmacology services performed to the highest ethical and quality standards. Our validated and customized behavioral studies can help to quantify the efficacy of your compounds before they move into clinic by:
> Establishing proof of concept & mechanism of action for drug candidates,
> Achieving the critically important positioning of these agents within precise therapeutic categories (cancer
pain, neuropathic pain, visceral pain, …),
> Benchmarking drug candidates with clinical gold standards.
We aim to act as an extension of your scientific team wherever you are located around the world, helping you to optimize and accelerate the development of your drug candidates.
In order to support the early stages of drug discovery for its clients, ANS Biotech established a unique in vivo High Throughput Screening tool (ALGOGramTM) that provides a rapid and cost-effective means to systematically explore pain indications for new chemical entities.
The ALGOGramTM is based on a battery of 11 validated models/tests spanning a broad range of pain areas – acute and tonic pain, neuropathic pain, inflammatory pain, post operative pain, and visceral pain. Results generated in the ALGOGramTM are assembled in a summary table format that provides a ready evaluation of a compound for potential efficacy, both in the context of reference drugs and standard measures of behavioral toxicity. The ALGOGramTM can provide a user-friendly pharmacological compound profile in only 3 weeks, facilitating the crucial “GO / NO GO” decisions routinely faced by pharmaceutical companies.
ANS Biotech has not received any reviews.
ANS Biotech has not received any endorsements.